Patients with advanced and early CKD are more likely to try new medicines

March 22, 2022 Read for 2 minutes Source / Disclosure Issuer: Disclosure: Damron has not reported disclosure of relevant financial information. Add topics to email alerts Receive an email when a new article is posted Please enter your email address to receive emails when new articles are posted .. "data-action " subscribe "> Subscribe The request could not be processed. Please try again later.If you continue to have this issue, please contact us customerservice@slackinc.com.. Return to Healio Patients with chronic kidney disease are willing to take on some risks of new medicines as their disease progresses. Kidney medicine. In addition, researchers have discovered that doctors may consider initiating a risk-benefit conversation with a patient when prescribing a new drug to slow the progression of the disease. Source: Adobe Stock “Risk prediction tools may improve the selection of patients who are most likely to benefit from interventions that reduce the risk of CKD progression, but why some patients progress and others do not. There is still much to learn about. Patients may not be able to quantify their risks to weigh the benefits of early treatment. " Kelly Collins DamronMSW, Written by the National Kidney Foundation and by a colleague. In addition, "There are no side-effect-free treatments, so it is especially important to understand concerns about side effects that can affect your willingness to take. dosage.. " In 2020, the NKF and FDA co-sponsored a science workshop to determine what patients should consider when taking new medicines. Researchers have developed an online observational study for a workshop to assess the willingness of patients with CKD to take new drugs with adverse events that may slow the progression of the disease. In November 2020, NKF sent the survey to an email database and posted a link to the survey online. Overall, 1,029 patients with CKD responded, 55% of whom were identified as non-dialysis and 26% were identified as kidney transplant recipients. Damron and his colleagues write: risk A scenario that asks respondents to consider the benefits of taking a new drug and whether to take a new drug that reduces the risk of developing renal failure in the next 20, 10, or 5 years. created. The risk of developing renal failure during these periods is 20%. " Through 26 questions, researchers asked patients to rate the risk of adverse drug events on a five-point scale, rating drug factors as non-essential, important, or very important. .. Analysis of the results revealed that patients are more likely to take new medications that slow the progression of kidney disease (33% to 47% in 20-5 years). However, some patients were willing to take the drug at risk (12.1%, 9.7%, 11.9%, 20 years, 10 years, 5 years, respectively) until renal failure. In order of importance, the patient determines the severity of known adverse events (60.6% very important), cost or insurance (57.9% very important), and what the doctor recommends (55.4% very important). I considered it the most important factor. Taking new medicine. Patients were least worried about how often they had to take medicine. The researchers noted that the study lacked a large population and limited data on the patients involved. Damron and his colleagues write: Presenting the difference, and the risk to the patient, helps to increase the clinician's comfort in these difficult but necessary conversations. " Add topics to email alerts Receive an email when a new article is posted Please enter your email address to receive emails when new articles are posted .. "data-action " subscribe "> Subscribe The request could not be processed. Please try again later.If you continue to have this issue, please contact us customerservice@slackinc.com.. Return to Healio Sources 1/ https://Google.com/ 2/ https://www.healio.com/news/nephrology/20220322/patients-with-advanced-vs-early-ckd-more-likely-to-try-new-medications The mention sources can contact us to remove/changing this article

ExBulletin

Patients with advanced and early CKD are more likely to try new medicines

Health

Patients with advanced and early CKD are more likely to try new medicines

Issuer:

Related

Recent Posts

Add ExBulletin to your Home screen!